Structured evidence table for Probiotics Skin Barrier Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Probiotics Skin Barrier Randomized Trial | objective Theof this paper is to analyze the available scientific evidence on the cutaneous microbiome and its relationship with skin health. | 4 | Taléns‐Visconti Raquel (2026) | Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions |
| Probiotics Skin Barrier Randomized Trial | acnes 14 15 16 2 15 12 12 2 3 3 17 18 19 13 15 16 The skin microbiome shifts notably throughout life, from the low diversity observed in newborns, to the emergence of lipophilic species with puberty, and typically an increase in overall alpha diversity in older adults due to reduced dominance of protective commensals such asand, coupled with higher representation of environmental/transient species [,]. | 4 | Taléns‐Visconti Raquel (2026) | Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions |
| Probiotics Skin Barrier Randomized Trial | A study found that women exhibit higher alpha diversity than men, indicating a richer and more balanced microbiota []. | 4 | Taléns‐Visconti Raquel (2026) | Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions |
| Probiotics Skin Barrier Randomized Trial | 1 Human skin, owing to its large surface area, plays a key role as the primary point of direct contact with the environment. | 4 | Taléns‐Visconti Raquel (2026) | Cosmetic Interventions for Skin Microbiome Modulation: Current Strategies and Future Directions |
| Probiotics Skin Barrier Randomized Trial | Elevated reactive oxygen species (ROS) also play a key role, as increased ROS levels are found in patients with rosacea []. | 4 | Muacevic Alexander (2026) | The Role of Biotics in Rosacea: A Narrative Review |
| Probiotics Skin Barrier Randomized Trial | Mendelian randomization studies have linked certain bacterial taxa, including uncategorized[] andspecies [], to an increased risk of rosacea, while other taxa appear to confer a protective effect []. | 4 | Muacevic Alexander (2026) | The Role of Biotics in Rosacea: A Narrative Review |
| Probiotics Skin Barrier Randomized Trial | Although these studies provide limited mechanistic insight, they strengthen the evidence that microbial composition influences disease risk and expression. | 4 | Muacevic Alexander (2026) | The Role of Biotics in Rosacea: A Narrative Review |
| Probiotics Skin Barrier Randomized Trial | General features of rosacea 1 2 4 Rosacea is a chronic inflammatory skin condition affecting about 5.5% of adults, mainly aged 30-50. | 4 | Muacevic Alexander (2026) | The Role of Biotics in Rosacea: A Narrative Review |
Source documents